ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fibroblasts, Synovial"

  • Abstract Number: LB05 • ACR Convergence 2025

    ER Stress-Induced ATP2A3 Drives Rheumatoid Arthritis via Activation of STING Signaling

    yujie cai, Nanfang hospital, Guangzhou, China (People's Republic)

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by persistent synovial inflammation and joint bone destruction. Endoplasmic reticulum (ER) stress plays an important role…
  • Abstract Number: 0797 • ACR Convergence 2025

    Spatial transcriptomics identifies density-sensing fibroblasts in synovial lining

    Sonia Presti1, Kseniia Anufrieva2, Ce Gao3, Sean Prell2, Philip Blazar2, Jeffrey Lange2, Morgan Jones2, Mihir Wechalekar4, Michael Brenner2, Ilya Korsunsky5, Shideh Kazerounian2 and Kevin Wei6, 1Standford University, Stanford, 2Mass General Brigham, Boston, 3Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Harvard Medical School, Boston, MA, 4Flinders Medical Centre, Adelaide, Australia, 5Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Division of Genetics, DOM, BWH; Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital at Harvard Medical School, Boston, MA

    Background/Purpose: The synovial lining is crucial for joint homeostasis, forming a barrier and producing lubricants through specialized fibroblasts. These fibroblasts differ from sublining fibroblasts, which…
  • Abstract Number: 0798 • ACR Convergence 2025

    Inhibition of Wnt Signaling Attenuates Inflammatory Arthritis Severity

    Alisa Mueller1, Angela Zou2, Lucy-Jayne Marsh3, Samuel Kemble3, Saba Nayar3, Gerald Watts4, Cassandra Murphy5, Emily Taylor3, Triin Major3, David Gardner6, Christopher Buckley7, Kevin Wei8, Soumya Raychaudhuri5, ilya Korsunsky5, Andrew Filer9, Adam Croft10 and Michael Brenner11, 1Stanford University and VA Palo Alto Health Care System, Stanford, CA, 2Harvard Medical School, Boston, MA, 3University of Birmingham, Birmingham, United Kingdom, 4Harvard Medical School, Brookline, MA, 5Brigham and Women's Hospital, Boston, MA, 6University of Birmingham, Havelock North, New Zealand, 7University of Oxford, Oxford, United Kingdom, 8Brigham and Women's Hospital at Harvard Medical School, Boston, MA, 9The University of Birmingham, Birmingham, United Kingdom, 10University of Birmingham, Hagley, Stourbridge, United Kingdom, 11Brigham and Women's Hospital, Harvard Medical School, Newton, MA

    Background/Purpose: Fibroblasts are critical in promoting pathogenic synovial inflammation and bone erosion in rheumatoid arthritis (RA). Moreover, recent studies have pointed to their potential contribution…
  • Abstract Number: 0472 • ACR Convergence 2025

    Detrimental Effects of Umbilical Cord Blood-derived Mesenchymal Stem Cells Intra-articular Injections on Pannus Invasiveness

    Sung Eun Kim1, Hye Lim Kang1, Min Jung Kim2, Hyung-Sik Kim3 and Kichul Shin4, 1Division of Rheumatology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea, 2Seoul Metropolitan Government Boramae Medical center, Dongjak-gu, Seoul, South Korea, 3Department of Oral Biochemistry, Pusan National University School of Dentistry, Yangsan, Republic of Korea, 4Seoul National University, Seoul, South Korea

    Background/Purpose: Studies have shown that mesenchymal stem cell (MSC) infusion ameliorates arthritis in animal models. However, the first-pass effect in the lung has directed attention…
  • Abstract Number: 2613 • ACR Convergence 2025

    Ga-FAPI-04 PET/CT reveals increased fibroblast activation in synovial and enthesial tissues of psoriasis patients with arthralgia and predicts the development of psoriatic arthritis

    Giulia Corte1, Koray Tascilar2, armin Atzinger3, Alp Temiz2, Melek Yalcin Mutlu4, Rita Noversa de Sousa5, Maria Gabriella Raimondo6, Andreas Ramming7, Sara Bayat2, Michael Sticherling8, Torsten Kuwert9, Christian Schmidkonz9, Georg Schett10 and Filippo Fagni11, 1- Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany, 3Department of Nuclear Medicine, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 4Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, erlangen, 5Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, 6Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, 7Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) & Universitätsklinikum Erlangen, Erlangen, Germany, 8Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 9Department of Nuclear Medicine, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, 10Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, Germany, 11Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Bayern, Germany

    Background/Purpose: 68Ga-FAPI-04 PET/CT reveals fibroblast activation in vivo and is increasingly used to assess rheumatic diseases, including inflammatory arthritides. (1,2) We previously demonstrated that the…
  • Abstract Number: 0096 • ACR Convergence 2025

    GLUT1-Dependent Targeting and Enhanced Selectivity of a Glucose-Methotrexate Conjugate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

    Sebastian Makuch1, Jacek Polański1 and Wojciech Tański2, 1Wrocław Medical University, Wrocław, Poland, 2Wrocław University of Science and Technology, Wrocław, Poland

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease where fibroblast-like synoviocytes (FLS) play a central role in joint inflammation and destruction. Methotrexate (MTX), a…
  • Abstract Number: 2285 • ACR Convergence 2025

    Synovium-on-a-chip – Development of a Humanized Rheumatoid Arthritis Model that Mimics Disease and Patient Biological Heterogeneity

    Theresa Wampler Muskardin1, Ruiqi Chen2, Yeji Lee3, Azka Ali3, Andrra Nimoni3, Christele Felix3, Hattie Heiland3, Romy Kallas3, Daniel Ramirez4, David Mayman3, Timothy Niewold5 and Weiqiang Chen6, 1Hospital for Special Surgery and Weill Cornell Medicine, New York, NY, 2New York University - Tandon School of Engineering, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5Hospital for Special Surgery, New York, New York, 6New York University, Tandon School of Engineering, New York, NY

    Background/Purpose: In rheumatoid arthritis (RA), reasons for treatment resistance and alternate strategies that would be more effective in treatment-resistant patients remain unknown. Accurate methodology to…
  • Abstract Number: 0097 • ACR Convergence 2025

    Aberrant histone marks increase the inflammatory phenotype of rheumatoid arthritis fibroblast-like synoviocytes (RA FLS) by suppressing NUB1 induction

    Yosuke Ono1, Camilla R.L. Machado2, Eunice Choi1, Wei Wang1, David Boyle1 and Gary Firestein2, 1University of California, San Diego, San Diego, 2University of California, San Diego, San Diego, CA

    Background/Purpose: Fibroblast-like synoviocytes (FLS) play a central role in cartilage destruction and cytokine production in rheumatoid arthritis (RA). Neddylation, a post-translational modification involving NEDD8 conjugation,…
  • Abstract Number: 1801 • ACR Convergence 2025

    Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype

    Richard Loeser1, Jorge Fernandez Davila1, Philip Coryell2, Susan Chubinskaya3 and Doug Phanstiel4, 1University of North Carolina, Chapel Hill, NC, 2University of North Carolina-Chapel Hill, Chapel Hill, NC, 3University of Texas Medical Branch, Galveston, TX, 4University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Protease cleavage of matrix proteins generates matrix fragments including fibronectin fragments (FN-f) found in OA cartilage and synovial fluid. Matrix fragments or “matrikines” activate…
  • Abstract Number: 0081 • ACR Convergence 2025

    Trans-endothelial Trafficking of Fibroblast-like Synoviocytes Amplifies Synovial Inflammation in Rheumatoid Arthritis

    Jaeyeon Kim1, Sanaz Panahandeh2, Hieu Nguyen3, Kainat Mian4, Hadijat Makinde4, Kyoung Jae Won5, Arminja Kettenbach3, Harris R Perlman4, Costantino Pitzalis6 and Nunzio Bottini7, 1Cedars Sinai Medical Center, Los Angeles, CA, 2Cedars-Sinai Medical Center, Los Angeles, 3Geisel School of Medicine at Dartmouth, Lebanon, NH, 4Northwestern University, Chicago, IL, 5Cedars-Sinai Medical Center, Los Angeles, CA, 6QMUL, Bromley Kent, United Kingdom, 7Cedars Sinai Medical Center, Beverly Hills, CA

    Background/Purpose: The discovery of circulating fibroblast-like synoviocyte (FLS), known as PRIME cells, in RA patients suggests that synovial FLS may enter the circulation through blood…
  • Abstract Number: 1787 • ACR Convergence 2025

    Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform

    Estefania Quesada-Masachs1, Luis Peñaranda Bolaño1, Aakriti Arora2, Jessica Murillo-Saich3, Edward Lo4, Tad George4, Daniel Tanoeihusada4, Sara McArdle5 and Monica Guma6, 1University of Miami, Miami, FL, 2University of Miami / Jackson Memorial Hospital, Miami, FL, 3University of California, San Diego, San Diego, CA, 4RareCyte, Seattle, WA, 5La Jolla Institute for Immunology, La Jolla, CA, 6University of California San Diego, San Diego, CA

    Background/Purpose: Although not part of the formal ACR criteria for RA, PsA, or OA, synovial pathology can be a helpful tool in clinical practice. Histopathologic…
  • Abstract Number: 0075 • ACR Convergence 2025

    Impact of CXCL2 and IL-11 from Rheumatoid Arthritis Synovial Fibroblasts on Angiogenesis and Endothelial Cell Network Formation

    Elena Neumann1, Frederik Loetfering2, Paula Welbrink3, Corinna Heck3, Daria Kuersammer3, Klaus Frommer1, Stefan Rehart4 and Ulf Müller-Ladner1, 1Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Justus-Liebig-University, Germany, Bad Nauheim, Hessen, Germany, 2Justus Liebig University Giessen, Campus Kerckhoff, Bad Nauheim, 3Justus-Liebig-Universität Gießen, Campus Kerckhoff, Bad Nauheim, Germany, 4Agaplesion Markus Hospital, Frankfurt, Hessen, Germany

    Background/Purpose: In rheumatoid arthritis (RA), hypervascularization contributes to synovial inflammation. RA synovial fibroblasts (RASF) contribute to cartilage and bone erosion but also promote angiogenesis. Activated…
  • Abstract Number: 1780 • ACR Convergence 2025

    Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts

    Abdelhak Belmadani1, Dongjun Ren1, Daniel Hoffman2, Nirupa Jayraj1, Paola Pacifico1, Vince Truong3, Patrick Walsh3, Daniela Menichella1, Anna Rapp4, Carla Scanzello5, Rachel Miller6, Richard Miller7 and Anne-Marie Malfait8, 1Northwestern University Chicago, Chicago, IL, 2Rush University, Chicago, IL, 3Anatomic Inc, Minneapolis, MN, 4University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, 6Rush University Medical Center, Chicago, IL, 7Northwestern University, Chicago, 8Rush University Medical Center, Chicago

    Background/Purpose: Joint pain is one of the most significant clinical hallmarks of knee osteoarthritis (OA). Knee OA is a chronic degenerative disease of the joints…
  • Abstract Number: 0069 • ACR Convergence 2025

    Spatial transcriptomics in rheumatoid arthritis (RA) synovium reveals distinct region-specific fibroblast functions

    Camilla R.L. Machado1, Mina Yao1, David Boyle2, Robert J. Benschop3, James T. Parker3, Wei Wang2 and Gary Firestein1, 1University of California, San Diego, San Diego, CA, 2University of California, San Diego, San Diego, 3Eli Lilly, San Diego

    Background/Purpose: RA synovium displays cellular heterogeneity, with gene expression driving disease pathogenesis. Unbiased cell-specific transcriptomes in RA synovium have previously relied primarily on disaggregated tissues…
  • Abstract Number: 1757 • ACR Convergence 2025

    Skin-to-Joint Immune Cell Migration and Synovial Reprogramming in Psoriatic Arthritis Onset

    Maria Gabriella Raimondo1, Hashem Mohammadian2, Mario Angeli2, Vladyslav Fedorchenko2, Kaiyue Huang3, Yi-Nan Li4, Raphael Micheroli5, Jörg Distler6, Ursula Fearon7, Juergen Rech2, Francesco Ciccia8, Juan Cañete9, Adam Croft10, Mariola Kurowska-Stolarska11, Stefano Alivernini12, Maria Antonietta D'Agostino13, Georg Schett2, Simon Rauber14 and Andreas Ramming15, 1Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, 2Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, Germany, 3Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, 4University Hospital of Düsseldorf, Düsseldorf, Germany, 5University Hospital Zurich, Zurich, Switzerland, 6University Hospital Duesseldorf and HHU, Duesseldorf, Germany, 7Trinity College Dublin, Dublin, Dublin, Ireland, 8Rheumatology Section, University of Campania L. Vanvitelli, Naples, Italy, Naples, Italy, 9Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona, Spain, Barcelona, Spain, 10University of Birmingham, Hagley, Stourbridge, United Kingdom, 11University of Glasgow, Glasgow, 12Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 13Division of Rheumatology and Clinical Immunology - Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 14Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, Bayern, Germany, 15Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) & Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Psoriatic arthritis (PsA) develops in about 30% of individuals with psoriasis (PsO), highlighting a critical connection between skin and joint inflammation. However, the mechanisms…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology